ADOCY (Adocia) 3-Month Share Buyback Ratio: 0.00% (As of Dec. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADOCY Adocia ADOCY
15 GF Score
Price $11.80
GF Value $2.51
! 7 Warning Signs
View Full Analysis

What is Adocia 3-Month Share Buyback Ratio?

Adocia ADOCY 15 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus rates ADOCY with a GF Score™ of 15/100 and a GF Value™ of $2.51. The stock has 7 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

ADOCY
15GF Score
Adocia ADOCY
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
Adocia (ADOCY) has a 3-Month Share Buyback Ratio of 0.00 as of Dec. 2025. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Adocia and its competitors.
Is Adocia's 3-Month Share Buyback Ratio too high?
Adocia's current 3-Month Share Buyback Ratio is 0.00. Overall, Adocia has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Adocia's 3-Month Share Buyback Ratio compare to VRTX and REGN?
Adocia's 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Biotechnology company?
A good 3-Month Share Buyback Ratio depends on the Biotechnology industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Adocia and its competitors. Adocia's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adocia stock overvalued right now?
Adocia (ADOCY) has a current 3-Month Share Buyback Ratio of 0.00. The stock's GF Value™ is $2.51, compared to a current price of $11.80 — trading 370.1% above its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. Adocia's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Adocia (ADOCY), the current 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adocia (ADOCY) Overvalued in 2026?

Based on GuruFocus' analysis, Adocia stock appears to be overvalued. The current stock price of $11.80 is trading 370.1% above its estimated GF Value™ of $2.51.

Key valuation signals for ADOCY:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: $2.51 vs. price of $11.80 (370.1% above fair value)
  • GF Score™: 15/100 with 7 warning signs

No single metric tells the full story. See the ADOCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adocia Business Description

Address 115 Avenue Lacassagne, Lyon, FRA, 69003
Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The firm has developed Biochaperone, a proprietary technology platform to enhance the effectiveness of therapeutic proteins. The company's clinical pipeline includes Biochaperone Lispro, Biochaparone Combo, Biochaparone Glucagon, and others. Its pre-clinical pipeline includes BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.
15GF Score

Get the complete analysis for ADOCY

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.80
Price
$2.51
GF Value